Therapeutic Advances in Psychopharmacology

Papers
(The median citation count of Therapeutic Advances in Psychopharmacology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping78
Analysis of the clinical characteristics of olanzapine-induced acute pancreatitis44
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review41
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK high-secure hospital39
Prevalence and predictors of inappropriate prescribing in outpatients with severe mental illness38
History repeating: guidelines to address common problems in psychedelic science38
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial34
The missing link? Pharmacists’ perspectives on discontinuation of long-term antidepressants: a qualitative study33
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study25
Comment on: History repeating: guidelines to address common problems in psychedelic science24
Who is prescribed valproate and how carefully is this treatment reviewed in UK mental health services? Data from a clinical audit23
Psychotropic medications versus non-pharmacologic approaches for managing behavioural and psychological symptoms in Australian aged care residents with dementia: general practitioners’ and physicians’22
Incidence of hyperthyroidism in patients with bipolar or schizoaffective disorder with or without lithium: 21-year follow-up from the LiSIE retrospective cohort study22
The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes20
Reasons for discontinuing and restarting lithium multiple times: a case-register study based on the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search system19
Corrigendum to “Managing medical and psychiatric multimorbidity in older patients”19
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?19
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry18
Reasons for admission to a general medical hospital for patients taking clozapine17
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia15
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review15
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey14
Clinical outcomes following switching antipsychotic treatment due to market withdrawal: a retrospective naturalistic cohort study of pipotiazine palmitate injection (Piportil Depot) discontinuation, s14
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?14
Risperidone-induced priapism: a case report and literature review14
Exploring the clinical factors affecting lithium dose and plasma level and the effect of brand13
Impact of CYP1A , CYP2C19 , CYP2D6 , CYP3A4 , CYP3A5 13
Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors13
Risperidone-induced neuroleptic malignant syndrome: a case report13
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review13
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia12
Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications12
Will psilocybin lose its magic in the clinical setting?12
Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’11
Anticholinergic action is rarely a good thing9
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies9
Duration of prior psychotic illness and clozapine response: a retrospective observational study using electronic health records8
Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomes8
Decreased citalopram concentration caused by enzyme induction effect of rifampin: a case report8
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression7
High-dose olanzapine in treatment-resistant schizophrenia: a systematic review7
Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study7
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series7
The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance7
Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders7
Drug safety in older patients with alcohol use disorder: a retrospective cohort study6
Risperidone ISM®: review and update of its usefulness in all phases of schizophrenia6
Increased amisulpride serum concentration in a patient treated with concomitant pregabalin and trazodone: a case report6
Clozapine blood level assessment using a point-of-care device: feasibility and reliability6
Tardive dyskinesia: understanding current challenges in diagnosis and treatment6
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence5
Classic psychedelics, health behavior, and physical health5
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics5
Time to rehospitalization in involuntarily hospitalized individuals suffering from schizophrenia discharged on long-acting injectable antipsychotics or oral antipsychotics5
Altered orbitofrontal and pars opercularis cortical thickness in betel quid dependence chewers5
Can the use of long-acting injectable antipsychotic preparations be increased in routine clinical practice and the benefits realised?5
Ketamine-assisted therapy within a community of practice: a novel approach to disordered eating5
The cardiovascular safety of tricyclic antidepressants in overdose and in clinical use5
Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan5
The place of long-acting injectable antipsychotics in the treatment of schizophrenia5
Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area5
Psychosocial interventions to improve adherence in depressed and anxious older adults prescribed antidepressant pharmacotherapy: a scoping review5
Managing medical and psychiatric multimorbidity in older patients4
Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study4
The past, present and future of anticholinergic drugs4
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review4
Drug utilization in geriatric psychiatric patients in the emergency department—a cohort study under real-world conditions4
Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study4
Olanzapine for the treatment of ICU delirium: a systematic review and meta-analysis4
Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis4
Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery4
0.036615133285522